ALX Oncology has found a new chief medical officer, tapping Alan Sandler for the role. Sandler comes to ALX from Mirati, ...
Evotec, a drug discoverer facing challenges under CEO Christian Wojczewski, confirmed receiving the unsolicited offer. The ...
Adaptimmune is slashing its headcount as part of a broader company restructuring aimed at saving $300 million ...
Eli Lilly is now the second drugmaker to propose a rebate model for 340B drug price discounts — and the second to ...
The European Medicines Agency has flipped its stance on Eisai and Biogen’s Alzheimer’s treatment Leqembi, recommending ...
Sen. Bill Cassidy (R-LA) will take over the Senate Health, Education, Labor, and Pensions Committee when the GOP gets control ...
More cuts are hitting Gilead’s cell therapy wing, including the closure of a Philadelphia office. A small number of ...
The European Commission is seeking feedback from industry players about Novo Holdings' $16.5 billion proposed acquisition of ...
New Zealand approved Tune Therapeutics' TUNE-401, an epigenetic editing therapy for chronic hepatitis B, for human trials.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Zai Lab announces $200M share offering amid 47% revenue growth and plans for KarXT submission in China. Multiple companies report changes: Kronos Bio seeks alternatives, Allogene halts trial ...
Lonza, WuXi Biologics, and Baxter Healthcare announce facility expansions and updates. Repligen reports revenue growth, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback